Parastoo Azadi Selected Research

Parastoo Azadi Research Topics

Disease

14	Infections 08/2024 - 11/2015
12	Neoplasms (Cancer) 02/2023 - 10/2006
8	COVID-19 03/2024 - 01/2021
5	Inflammation (Inflammations) 04/2024 - 04/2015
4	Virus Diseases (Viral Diseases) 12/2023 - 10/2022
4	Cholangiocarcinoma 02/2021 - 01/2016
3	Glanders 01/2012 - 02/2011
2	Premature Aging 04/2024 - 12/2023
2	Neuroblastoma 02/2023 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2023
2	Human Influenza (Influenza) 01/2021 - 01/2013
2	red meat allergy 01/2020 - 01/2019
2	Hypersensitivity (Allergy) 01/2020 - 01/2019
2	Thrombosis (Thrombus) 07/2015 - 07/2013
2	Lafora Disease 01/2015 - 03/2011
2	Osteoarthritis 01/2012 - 01/2007
1	Dental Caries (Decay, Dental) 05/2024
1	HIV Infections (HIV Infection) 04/2024
1	Intellectual Disability (Idiocy) 11/2023
1	Memory Disorders (Memory Loss) 11/2023
1	Cholera 08/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Dehydration (Water Stress) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Coinfection 01/2023
1	Ascites 01/2023
1	Circulating Neoplastic Cells 01/2023
1	Type 2 von Willebrand Disease 01/2022
1	Gastroenteritis 11/2021
1	Campylobacter Infections (Campylobacter Infection) 11/2021
1	Weight Loss (Weight Reduction) 11/2021
1	Chronic Granulomatous Disease 03/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Glucose Intolerance 01/2021
1	Invasive Fungal Infections 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020

Drug/Important Bio-Agent (IBA)

22	Polysaccharides (Glycans)IBA 04/2024 - 10/2006
11	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2006
8	Glycoproteins (Glycoprotein)IBA 08/2023 - 01/2009
8	VaccinesIBA 11/2021 - 01/2012
6	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2023 - 11/2015
6	AntibodiesIBA 01/2023 - 01/2016
4	GlycoconjugatesIBA 11/2023 - 01/2012
4	AntigensIBA 01/2023 - 10/2006
4	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2018
3	CarbohydratesIBA 05/2024 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2020
3	Heparitin Sulfate (Heparan Sulfate)IBA 11/2023 - 01/2014
3	LigandsIBA 01/2023 - 01/2018
3	Monoclonal AntibodiesIBA 01/2022 - 10/2006
3	EnzymesIBA 01/2018 - 01/2012
2	Immunoglobulin G (IgG)IBA 04/2024 - 01/2018
2	GlycolipidsIBA 08/2023 - 03/2021
2	Neutralizing AntibodiesIBA 01/2023 - 01/2022
2	Sialic AcidsIBA 02/2021 - 11/2015
2	Subunit VaccinesIBA 01/2021 - 02/2011
2	MucinsIBA 10/2020 - 01/2019
2	GangliosidesIBA 07/2020 - 11/2015
2	OligosaccharidesIBA 01/2020 - 01/2019
2	Phosphates (Orthophosphate)IBA 01/2015 - 03/2011
2	GlycogenIBA 01/2015 - 03/2011
2	Glucosamine (Dona)IBA 01/2012 - 01/2007
2	EpitopesIBA 01/2012 - 10/2006
1	BuffersIBA 08/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	SugarsIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Cholera ToxinIBA 08/2023
1	alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase IIBA 02/2023
1	MesothelinIBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Broadly Neutralizing AntibodiesIBA 01/2022
1	PENTAIBA 03/2021
1	Lipid AIBA 03/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2021
1	AcidsIBA 03/2021
1	Galactose (Galactopyranose)FDA LinkGeneric 02/2021
1	AcetylglucosamineIBA 02/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Heparin Lyase (heparin lyase)IBA 01/2021
1	Viral ProteinsIBA 01/2021
1	aluminum sulfate (alum)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	mouse dectin-2IBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	aminoquinuride (Surfen)IBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Serine (L-Serine)FDA Link 10/2020
1	GlobosidesIBA 07/2020
1	G(M2) Ganglioside (Ganglioside GM2)IBA 07/2020
1	lactosidesIBA 07/2020
1	GlycosphingolipidsIBA 07/2020

Therapy/Procedure

8	Therapeutics 03/2024 - 10/2006
2	Art Therapy 04/2024 - 12/2023
1	Intranasal Administration 08/2024
1	Drug Therapy (Chemotherapy) 01/2023
1	Ligation 01/2021